Continued treatment of chronic hepatitis C despite development of interferon-associated retinopathy.
Cedar
Mark A
MA
Zancosky
Krysia L
KL
Oliva
Lisa A
LA
Molloy
Peter J
PJ
Weissgold
David J
DJ
Krawitt
Edward L
EL
D000998:Antiviral Agents / Q000009:adverse effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012164:Retinal Diseases / Q000139:chemically induced*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins